Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
Clinical trial NCT02063997 · COMPLETED
Trial details
- NCT number
- NCT02063997
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-01-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.